Nasal nitric oxide concentration in paranasal sinus inflammatory diseases

In normal upper airways, nitric oxide is generated by the paranasal sinus epithelium and then diffuses into the nasal cavities. This study examined whether or not nasal NO concentration is affected by paranasal sinus inflammatory diseases. The influence of obstruction (nasal polyposis) and/or inflammation (allergy or chronic sinusitis) of the paranasal sinuses on nasal NO concentration was evaluated in nasal allergic (n=7 patients) or nonallergic (n=20) polyposis, nonallergic chronic sinusitis (n=10) and Kartagener's syndrome (n=6) and compared with control subjects (n=42). A score of alteration of the paranasal sinus (number of altered and occluded sinuses) was determined by a computed tomography scan. The nasal NO concentration in nasal nonallergic polyposis (150+/-20 parts per billion (ppb)) was significantly decreased compared with both controls (223+/-6 ppb, p=0.01) and polyposis with allergy (272+/-28 ppb, p<0.0001). In each group, the nasal NO concentration was inversely correlated with the extent of tomodensitometric alteration of the paranasal sinuses. In Kartagener's syndrome, the nasal NO concentration (14+/-2 ppb) was drastically decreased compared with all other groups, despite the presence of open paranasal sinuses. Thus, the nasal NO concentration in patients with nasal polyposis appeared to be dependent on both the allergic status and the degree of obstruction of the paranasal sinuses.

This article has been cited by other articles:

				G. B. Lenon, C. G. Li, C. C. Xue, F. C. K. Thien, and D. F. Story Inhibition of Release of Vasoactive and Inflammatory Mediators in Airway and Vascular Tissues and Macrophages By a Chinese Herbal Medicine Formula for Allergic Rhinitis Evid. Based Complement. Altern. Med., June 1, 2007; 4(2): 209 - 217. [Abstract] [Full Text] [PDF]

				V. M. D. Struben, M. H. Wieringa, C. J. Mantingh, C. Bommelje, M. Don, L. Feenstra, and J. C. de Jongste Nasal NO: normal values in children age 6 through to 17 years Eur. Respir. J., September 1, 2005; 26(3): 453 - 457. [Abstract] [Full Text] [PDF]

				R. Corbelli, B. Bringolf-Isler, A. Amacher, B. Sasse, M. Spycher, and J. Hammer Nasal Nitric Oxide Measurements To Screen Children for Primary Ciliary Dyskinesia Chest, October 1, 2004; 126(4): 1054 - 1059. [Abstract] [Full Text] [PDF]

				M. Maniscalco, E. Weitzberg, J. Sundberg, M. Sofia, and J.O. Lundberg Assessment of nasal and sinus nitric oxide output using single-breath humming exhalations Eur. Respir. J., August 1, 2003; 22(2): 323 - 329. [Abstract] [Full Text] [PDF]

				M. Deja, T. Busch, S. Bachmann, K. Riskowski, V. Campean, B. Wiedmann, M. Schwabe, B. Hell, J. Pfeilschifter, K. J. Falke, et al. Reduced Nitric Oxide in Sinus Epithelium of Patients with Radiologic Maxillary Sinusitis and Sepsis Am. J. Respir. Crit. Care Med., August 1, 2003; 168(3): 281 - 286. [Abstract] [Full Text] [PDF]

				J. O. Lundberg, M. Maniscalo, M. Sofia, L. Lundblad, and E. Weitzberg Humming, Nitric Oxide, and Paranasal Sinus Obstruction JAMA, January 15, 2003; 289(3): 302 - 303. [Full Text] [PDF]

				T. Wodehouse, S.A. Kharitonov, I.S. Mackay, P.J. Barnes, R. Wilson, and P.J. Cole Nasal nitric oxide measurements for the screening of primary ciliary dyskinesia Eur. Respir. J., January 1, 2003; 21(1): 43 - 47. [Abstract] [Full Text] [PDF]

				I Horvath, S Loukides, T Wodehouse, E Csiszer, P J Cole, S A Kharitonov, and P J Barnes Comparison of exhaled and nasal nitric oxide and exhaled carbon monoxide levels in bronchiectatic patients with and without primary ciliary dyskinesia Thorax, January 1, 2003; 58(1): 68 - 72. [Abstract] [Full Text] [PDF]

				L. O. Cardell The Paranasal Sinuses and a Unique Role in Airway Nitric Oxide Production? Am. J. Respir. Crit. Care Med., July 15, 2002; 166(2): 131 - 132. [Full Text] [PDF]

				Members of the Task Force:, E. Baraldi, J.C. de Jongste, B. Gaston, K. Alving, P.J. Barnes, H. Bisgaard, A. Bush, C. Gaultier, H. Grasemann, et al. Measurement of exhaled nitric oxide in children, 2001: E. Baraldi and J.C. de Jongste on behalf of the Task Force Eur. Respir. J., July 1, 2002; 20(1): 223 - 237. [Abstract] [Full Text] [PDF]

				D C Chambers and J G Ayres Effect of nebulised L- and D-arginine on exhaled nitric oxide in steroid naive asthma Thorax, August 1, 2001; 56(8): 602 - 606. [Abstract] [Full Text] [PDF]

				M. PASTO, E. SERRANO, E. UROCOSTE, M.-A. BARBACANNE, A. GUISSANI, A. DIDIER, M.-B. DELISLE, J. RAMI, and J.-F. ARNAL Nasal Polyp-Derived Superoxide Anion . Dose-Dependent Inhibition by Nitric Oxide and Pathophysiological Implications Am. J. Respir. Crit. Care Med., January 1, 2001; 163(1): 145 - 151. [Abstract] [Full Text]

				H. NAKANO, H. IDE, M. IMADA, S. OSANAI, T. TAKAHASHI, K. KIKUCHI, and J. IWAMOTO Reduced Nasal Nitric Oxide in Diffuse Panbronchiolitis Am. J. Respir. Crit. Care Med., December 1, 2000; 162(6): 2218 - 2220. [Abstract] [Full Text]